Race, pharmacogenomics, and marketing: Putting BiDil in context Read more about Race, pharmacogenomics, and marketing: Putting BiDil in context
Identification of genetic susceptibility to common diseases: The case for regulation Read more about Identification of genetic susceptibility to common diseases: The case for regulation
Overseeing research on therapeutic cloning: A private ethics board responds to its critics Read more about Overseeing research on therapeutic cloning: A private ethics board responds to its critics
The marketing battle over genetically modified foods: False assumptions about consumer behavior Read more about The marketing battle over genetically modified foods: False assumptions about consumer behavior
Cases in genetics: Direct-to-consumer marketing for genetic testing Read more about Cases in genetics: Direct-to-consumer marketing for genetic testing
Are genetic self-tests dangerous? Assessing the commercialization of genetic testing in terms of personal autonomy Read more about Are genetic self-tests dangerous? Assessing the commercialization of genetic testing in terms of personal autonomy
Genetic testing for breast and ovarian cancer susceptibility: Evaluating direct-to-consumer marketing -- Atlanta, Denver, Raleigh-Durham, and Seattle, 2003 Read more about Genetic testing for breast and ovarian cancer susceptibility: Evaluating direct-to-consumer marketing -- Atlanta, Denver, Raleigh-Durham, and Seattle, 2003
Direct-to-consumer genetic testing: Access and marketing Read more about Direct-to-consumer genetic testing: Access and marketing
Marketing genetic tests: Empowerment or snake oil? Read more about Marketing genetic tests: Empowerment or snake oil?
